Apolipoprotein E immunoreactivity in cerebral amyloid deposits and neurofibrillary tangles in Alzheimer's disease and kuru plaque amyloid in Creutzfeldt-Jakob disease - PubMed (original) (raw)
Apolipoprotein E immunoreactivity in cerebral amyloid deposits and neurofibrillary tangles in Alzheimer's disease and kuru plaque amyloid in Creutzfeldt-Jakob disease
Y Namba et al. Brain Res. 1991.
Abstract
During the course of our immunohistochemical studies on the change of lipids in Alzheimer's disease brains by using antibody to apolipoprotein E, a protein having a special relevance to nervous tissue, we unexpectedly found that apo E immunoreactivity was associated with amyloid in both senile plaques and cerebral vessels and neurofibrillary tangles. The immunoreactivity was also found in amyloid of kuru plaques in Creutzfeldt-Jakob disease. Pretreatment of the sections with formic acid greatly enhanced immunoreactivity of senile and kuru plaques to antibody to apo E.
Similar articles
- A comparative immunohistochemical study of Kuru and senile plaques with a special reference to glial reactions at various stages of amyloid plaque formation.
Miyazono M, Iwaki T, Kitamoto T, Kaneko Y, Doh-ura K, Tateishi J. Miyazono M, et al. Am J Pathol. 1991 Sep;139(3):589-98. Am J Pathol. 1991. PMID: 1679596 Free PMC article. - Ultrastructural study of florid plaques in variant Creutzfeldt-Jakob disease: a comparison with amyloid plaques in kuru, sporadic Creutzfeldt-Jakob disease and Gerstmann-Sträussler-Scheinker disease.
Sikorska B, Liberski PP, Sobów T, Budka H, Ironside JW. Sikorska B, et al. Neuropathol Appl Neurobiol. 2009 Feb;35(1):46-59. doi: 10.1111/j.1365-2990.2008.00959.x. Epub 2008 May 30. Neuropathol Appl Neurobiol. 2009. PMID: 18513219 - Extracellular Amyloid Deposits in Alzheimer's and Creutzfeldt-Jakob Disease: Similar Behavior of Different Proteins?
Jankovska N, Olejar T, Matej R. Jankovska N, et al. Int J Mol Sci. 2020 Dec 22;22(1):7. doi: 10.3390/ijms22010007. Int J Mol Sci. 2020. PMID: 33374972 Free PMC article. Review. - [Apolipoprotein E4 and late-onset Alzheimer's disease].
Tamaoka A. Tamaoka A. Nihon Rinsho. 1994 Dec;52(12):3257-65. Nihon Rinsho. 1994. PMID: 7853720 Review. Japanese.
Cited by
- APOE genotype alters glial activation and loss of synaptic markers in mice.
Zhu Y, Nwabuisi-Heath E, Dumanis SB, Tai LM, Yu C, Rebeck GW, LaDu MJ. Zhu Y, et al. Glia. 2012 Apr;60(4):559-69. doi: 10.1002/glia.22289. Epub 2012 Jan 6. Glia. 2012. PMID: 22228589 Free PMC article. - The role of apolipoprotein E in Alzheimer's disease.
Kim J, Basak JM, Holtzman DM. Kim J, et al. Neuron. 2009 Aug 13;63(3):287-303. doi: 10.1016/j.neuron.2009.06.026. Neuron. 2009. PMID: 19679070 Free PMC article. Review. - Astrocytic APOE4 removal confers cerebrovascular protection despite increased cerebral amyloid angiopathy.
Xiong M, Wang C, Gratuze M, Saadi F, Bao X, Bosch ME, Lee C, Jiang H, Serrano JR, Gonzales ER, Kipnis M, Holtzman DM. Xiong M, et al. Mol Neurodegener. 2023 Mar 16;18(1):17. doi: 10.1186/s13024-023-00610-x. Mol Neurodegener. 2023. PMID: 36922879 Free PMC article. - F-spondin interaction with the apolipoprotein E receptor ApoEr2 affects processing of amyloid precursor protein.
Hoe HS, Wessner D, Beffert U, Becker AG, Matsuoka Y, Rebeck GW. Hoe HS, et al. Mol Cell Biol. 2005 Nov;25(21):9259-68. doi: 10.1128/MCB.25.21.9259-9268.2005. Mol Cell Biol. 2005. PMID: 16227578 Free PMC article. - System Xc- and apolipoprotein E expressed by microglia have opposite effects on the neurotoxicity of amyloid-beta peptide 1-40.
Qin S, Colin C, Hinners I, Gervais A, Cheret C, Mallat M. Qin S, et al. J Neurosci. 2006 Mar 22;26(12):3345-56. doi: 10.1523/JNEUROSCI.5186-05.2006. J Neurosci. 2006. PMID: 16554485 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical